Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LY2523355 in Patients With Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: August 11, 2011
Last updated: January 7, 2014
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 7, 2014